AGIO:Agios Pharmaceuticals Inc - Stock Price Quote and Dividend Data
AGIO STOCK PRICE LATEST CLOSE
$25.31
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Agios Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Agios Pharmaceuticals Inc Stock Price Information
52-Week Low/High Stock Price$23.42 - $62.58
Percent Held by Institutions82.82%
Revenue$47,228,000
Net Income$577,202,000
Cash Flow$-523,008,000
EPS-1.72%
Market Cap$1,450,161,760
PE Ratio to Industry119%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-15.46%
Total Return Last 3 Years-14.09%
Total Return Last 5 Years-36.53%
Latest Trade DateApr. 10, 2025
Agios Pharmaceuticals Inc Annual Stock Dividends
No Data available for Payment History.
Agios Pharmaceuticals Inc Dividend Payment History
| No dividends retrieved for AGIO |
Agios Pharmaceuticals Inc Other Dividend Details
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dec. 13, 2024AGIO STOCK PRICE DECREASE: Agios Pharmaceuticals Inc on 12-13-2024 decreased stock price > 10% from $43.37 to $38.17
Dec. 10, 2024AGIO STOCK PRICE DECREASE: Agios Pharmaceuticals Inc on 12-10-2024 decreased stock price > 10% from $61.64 to $48.64
Nov. 07, 2024AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 11-07-2024 increased stock price > 10% from $46.70 to $51.59
Jun. 04, 2024AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 06-04-2024 increased stock price > 10% from $36.34 to $43.83
May. 29, 2024AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 05-29-2024 increased stock price > 10% from $31.50 to $38.81
Feb. 24, 2024AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 02-24-2024 increased stock price > 10% from $29.78 to $32.99
Feb. 23, 2024AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 02-23-2024 increased stock price > 10% from $26.80 to $29.78
Sep. 09, 2022AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 09-09-2022 increased stock price > 10% from $30.00 to $34.00
Sep. 02, 2022AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 09-02-2022 increased stock price > 10% from $25.50 to $30.59
Aug. 05, 2022AGIO STOCK PRICE INCREASE: Agios Pharmaceuticals Inc on 08-05-2022 increased stock price > 10% from $24.95 to $28.61
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
